Sight Sciences (SGHT) Income towards Parent Company (2020 - 2026)
Sight Sciences' (SGHT) quarterly Income towards Parent Company came in at -$13.0 million in Q1 2026, up 8.29% year-on-year from -$12.0 million in Q1 2025, and down 211.87% quarter-over-quarter from -$4.2 million in Q4 2025.
Sight Sciences (SGHT) Income towards Parent Company (2020 - 2026) Analysis & Trends
Sight Sciences' Income towards Parent Company history runs 7 years deep, the most recent figure standing at -$13.0 million for Q1 2026.
- On a quarterly basis, Income towards Parent Company rose 8.29% year-over-year to -$13.0 million in Q1 2026; TTM through Mar 2026 was -$37.3 million, a 24.58% increase from a year earlier, with the FY2025 full-year figure at -$38.4 million, up 25.4% from the prior year.
- Income towards Parent Company declined to -$13.0 million in Q1 2026 per SGHT's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$4.2 million in Q4 2025 and bottomed at -$23.8 million in Q2 2022.
- The 5-year median for Income towards Parent Company is -$13.0 million (2023), against an average of -$14.4 million.
- Across the five-year window, Income towards Parent Company slumped 90.06% in 2022 and soared 64.87% in 2025, its largest moves.
- Year by year, Income towards Parent Company stood at -$16.9 million in 2022, then soared by 36.77% to -$10.7 million in 2023, then fell by 10.8% to -$11.8 million in 2024, then surged by 64.87% to -$4.2 million in 2025, then sank by 211.87% to -$13.0 million in 2026.
- Per Business Quant, the three latest SGHT Income towards Parent Company figures stand at -$13.0 million (Q1 2026), -$4.2 million (Q4 2025), and -$8.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Sight Sciences | 278.35 Mn | 193.38 Mn | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.98 Mn |
| Dec 31, 2025 | -4.16 Mn |
| Sep 30, 2025 | -8.17 Mn |
| Jun 30, 2025 | -11.94 Mn |
| Mar 31, 2025 | -14.15 Mn |
| Dec 31, 2024 | -11.85 Mn |
| Sep 30, 2024 | -11.07 Mn |
| Jun 30, 2024 | -12.33 Mn |
| Mar 31, 2024 | -16.27 Mn |
| Dec 31, 2023 | -10.69 Mn |
| Sep 30, 2023 | -13.04 Mn |
| Jun 30, 2023 | -14.75 Mn |
| Mar 31, 2023 | -17.07 Mn |
| Dec 31, 2022 | -16.91 Mn |
| Sep 30, 2022 | -22.23 Mn |
| Jun 30, 2022 | -23.84 Mn |
| Mar 31, 2022 | -23.26 Mn |
| Dec 31, 2021 | -15.94 Mn |
| Sep 30, 2021 | -17.17 Mn |
| Jun 30, 2021 | -17.62 Mn |